C12N 2760/20223
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2760/20223 (Virus like particles [vlp]) appears on 13 US grants and 32 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 32
- Assignees
- 27
- Inventors
- 70
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 3 |
| 2017 | 1 | 1 |
| 2018 | 2 | 0 |
| 2019 | 2 | 5 |
| 2020 | 4 | 0 |
| 2021 | 1 | 3 |
| 2022 | 0 | 1 |
| 2023 | 0 | 4 |
| 2024 | 0 | 7 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Enhanced virus-like particles and methods of use thereof for delivery to cells3 Jun 2025US 12,319,938 B2President and Fellows of Harvard College
- Zika virus vaccine21 Sep 2021US 11,123,423 B2President and Fellows of Harvard College
- Chimeric VSV virus compositions and methods of use thereof for treatment of cancer3 Nov 2020US 10,821,143 B2Yale University
- Vaccine composition26 May 2020US 10,660,947 B2Turnstone Limited Partnership
- Vaccine composition12 May 2020US 10,646,557 B2Turnstone Limited Partnership
- Enhanced virus-like particles and methods of use thereof for delivery to cells22 Jan 2026US 2026/0022349 A1The General Hospital Corporation
- Vsv vector-encoded hcv envelope proteins e1/e2 as vaccines against hepatitis c virus15 Jan 2026US 2026/0015593 A1Twincore Zentrum FüR Experimentelle Und Klinische Infektionsforschung GmbH
- Multivalent display on enveloped particles with human oligomerization domains18 Sep 2025US 2025/0288662 A1Achelois Biopharma, Inc.
- Compositions and methods for use in immunotherapy26 Dec 2024US 2024/0423927 A1Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Versatile virus-like-vesicles (vlv) platform for infectious diseases and cancer immunotherapy applications5 Dec 2024US 2024/0398921 A1Carogen Corporation
Most cited
By later US patents
- Methods and compositions for protein delivery25US 9,296,790 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016
- Methods and compositions for protein delivery23US 10,040,830 B2The United States of America, as represented by the Secretary, Dept. of Health and Human Services · 2018
- Methods and compositions for protein delivery6US 10,577,397 B2The USA, as represented by the Secretary, Dept. of Health and Human Services · 2020
- Lipoparticles comprising ion channels, methods of making and using the same5US 8,377,691 B2Integral Molecular, Inc. · 2013
- Vaccine composition2US 10,363,293 B2Turnstone Limited Partnership · 2019